Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Securities Fraud

A federal court in Indiana approved a $50 million settlement in a class action securities fraud case brought by investors against medical device company Zimmer Biomet Holdings. The investors claimed the company failed to disclose supply chain problems that led to a decrease in order fulfillment rates.

SOUTH BEND, Ind. — A federal court in Indiana approved a $50 million settlement in a class action securities fraud case brought by investors against medical device company Zimmer Biomet Holdings. The investors claimed the company failed to disclose supply-chain problems that led to a decrease in order fulfillment rates.

Categories / Business, Securities

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...